ArticleFrontiers in global women's health2026
The association between breastfeeding and prevalence of metabolic syndrome in women with a previous major pregnancy complication.
Article in Frontiers in global women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Maternal complications of pregnancy, including preeclampsia, gestational diabetes mellitus, spontaneous preterm birth and placental abruption are individually associated with an increased risk of premature heart disease. Breastfeeding may reduce early postpartum cardiometabolic risk in this group. This study aimed the association between breastfeeding and the prevalence of cardiovascular risk factors and metabolic syndrome (MetS) in the early postpartum period amongst women with previous pregnancy complication. Methods: We conducted a cross-sectional analysis of 524 women who attended an appointment in a postpartum cardiovascular disease prevention clinic for women with previous pregnancy complications (HREC: TQEH/16/LMH/258). Breastfeeding status was self-reported and cardiovascular disease risk factors were assessed at approximately 6 months postpartum. MetS was reported as a marker of cardiovascular health, defined using the Harmonising The Metabolic Syndrome definition. Statistical analysis was reported using SPSS Version 27. Results: Breastfeeding for >5.5 months postpartum was associated with a lower prevalence of abnormal lipids (based on triglyceride and High Density Lipoprotein cut-offs for MetS), lower prevalence of treated hypertension and systolic blood pressure >130 mmHg. Women who breastfed for >5.5 months were 53% less likely to have MetS at 6 months postpartum (aOR 0.47 95%, CI 0.29-0.77). The prevalence of breastfeeding for >5.5 months was higher for women with previous gestational diabetes mellitus (GDM) (GDM 55% vs. non-GDM 44%, Conclusion: Women who breastfeed for longer is associated with lower prevalence of MetS and its components in the early postpartum period. However, further studies are required to assess this association based on lactation intensity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.